Novartis | Debitur Perdagangan



Trade Debtors Perubahan Tanggal
AbbVie USD 10.92B 553M 2024-12
Alcon AG USD 2.08B 314M 2024-12
Almirall EUR 178.14M 31.11M 2024-06
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.82B 16M 2025-03
Autolus Therapeutics Ltd 48.24M 4.96M 2024-12
Bayer EUR 12.5B 1.33B 2024-12
Biogen USD 1.87B 119.3M 2024-12
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Eli Lilly USD 13.28B 1.22B 2024-12
Fresenius EUR 3.5B 317M 2024-12
Fresenius Medical Care EUR 3.37B 123M 2024-12
Galapagos EUR 83.49M 3.87M 2025-03
Genmab DKK 6.69B 381M 2024-12
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
GRIFOLS EUR 871.58M 135.79M 2024-12
Hikma Pharmaceutical USD 965M 92M 2024-06
J&J USD 14.84B 1.33B 2024-12
Lonza CHF 2B 406M 2024-12
Merck EUR 4.59B 127M 2024-12
Merck USD 11.12B 1.06B 2024-12
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Novo Nordisk 79.63B 3.5B 2024-09
Orion EUR 391.3M 900K 2025-03
Pfizer USD 14.78B 2.92B 2024-12
Philips EUR 3.77B 170M 2024-12
Recordati EUR 576.98M 15.22M 2024-09
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
UCB EUR 1.42B 132M 2024-06



Novartis Debitur Perdagangan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.